Psychiatry Research
Volume 105, Issue 1 , Pages 33-44 , 15 December 2001

Effects of long-term lithium treatment on monoaminergic functions in major depression

Received 18 January 2001 ,Revised 17 September 2001 ,Accepted 20 September 2001.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: Author; 1994;
  2. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochemical Journal. 1982;206:587–595
  3. Biegon A, Israeli M. Quantitative autoradiographic analysis of the effects of electroconvulsive shock on serotonin-2 receptor density in male and female rats. Journal of Neurochemistry. 1987;48:1386–1391
  4. Biegon A, Essar N, Israeli M, Elizur A, Bruch S, Bar-Nathan AA. Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder. Psychopharmacology. 1990;102:73–75
  5. Biegon A, Grinspoon A, Blumenfeld B, Bleich A, Apter A, Mester R. Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychopharmacology. 1990;100:165–167
  6. Blier P, De Montigny C. Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. European Journal of Pharmacology. 1985;113:69–77
  7. Born GVR, Grignany G, Martin K. Long-term effect of lithium on uptake of 5-hydroxytryptamine by human platelets. British Journal of Clinical Pharmacology. 1980;9:321–325
  8. Carli M, Reader TA. Regulation of central serotonin transporters by chronic lithium: autoradiographic study. Synapse. 1997;27:83–89
  9. Coppen A, Swade C, Wood K. Lithium restores abnormal 5-HT transport in patients with affective disorders. British Journal of Psychiatry. 1980;136:235–238
  10. Cowen PJ, McCance SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome. British Journal of Psychiatry. 1991;159:341–346
  11. Drummond AH. Lithium and inositol lipid-linked signaling mechanisms. Trends in Pharmacological Sciences. 1987;8:129–133
  12. Ebstein RP, Lerer B, Bennett ER, Shapira B, Kindler S, Shemesh Z, et al. Lithium modulation of second messenger signal amplification in man: inhibition of phosphatidylinositol-specific phospholipase C and adenylate cyclase activity. Psychiatry Research. 1988;24:45–52
  13. Garcia-Sevilla JA, Guimon J, Garcia-Vallejo P, Fuster MJ. Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment. Archives of General Psychiatry. 1986;43:51–57
  14. Gleiter CH, Nutt DJ. Chronic electroconvulsive shock and neurotransmitter receptors — an update. Life Sciences. 1989;44:985–1006
  15. Glue PW, Cowen PJ, Nutt DJ, Kolakowska T, Grahame-Smith DG. The effect of lithium on 5-HT-mediated neuroendocrine response and platelet 5-HT receptors. Psychopharmacology. 1986;90:398–402
  16. Goodwin GM, DeSouza RJ, Wood AJ, Green AR. Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2-adrenoceptor mediated function in mice. Psychopharmacology. 1986;90:482–487
  17. Hallcher LM, Sherman WR. The effect of lithium on ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry. 1980;255:10896–10901
  18. Healy D, Carney PA, Leonard BE. Monoamine-related markers of depression: changes following treatment. Journal of Psychiatric Research. 1982;17:251–260
  19. Imandt L, Tijhuis D, Wessels H, Haanen C. Lithium inhibits adenylate cyclase of human platelets. Thrombosis and Haemostasis. 1981;45:142–145
  20. Imandt L, Tijhuis D, Wessels H, Haanen C, van den Berg R, Thomas C. Lithium stimulates thromboxane B2 formation in human platelets. Prostaglandins and Medicine. 1981;7:421–429
  21. Kellar KJ, Cascio CS, Butler JA, Kurtzke RN. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. European Journal of Pharmacology. 1981;69:515–518
  22. Klompenhauer JL, Fekkes D, van Hulst AM, Moleman O, Pepplinkhuizen L, Mulder PG. Seasonal variation in binding of 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference. Biological Psychiatry. 1990;28:364–369
  23. Lingjaerde O. Platelet uptake and storage of serotonin. In:  Essman WR editors. Serotonin in Health and Disease. 4:New York: Spectrum Publications; 1977;p. 129–199
  24. Maeda K, Tanimoto K, Terada T. Chronic lithium treatment decreases [3H]-imipramine binding in rat brain. Japanese Journal of Psychiatry and Neurology. 1986;40:227–230
  25. Majerus PW. Inositol phosphate biochemistry. Annual Review of Biochemistry. 1992;61:225–250
  26. Malmgren R. Platelet and biogenic amines. 1. Platelets are poor investigative models for dopamine re-uptake. Psychopharmacology. 1984;84:480–485
  27. Malmgren R, Åberg-Wistedt A, Mårtensson B. Aberrant seasonal variations of platelet serotonin uptake in endogenous depression. Biological Psychiatry. 1989;25:293–402
  28. Malmgren R. The potentiating effect of serotonin and epinephrine on collagen-induced whole blood aggregation and secretion. Platelets. 1990;1:213–215
  29. Malmgren R, . Åberg-Wistedt A, Eneroth P. Lithium interferes with seasonal modulation of platelet serotonin uptake in depression. Lithium. 1991;2:149–153
  30. McCance SL, Cohen PR, Cowen PJ. Lithium increases 5-HT-mediated prolactin release. Psychopharmacology. 1989;99:276–281
  31. Meltzer HY, Arora RC, Goodnick PJ. Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders. Journal of Affective Disorders. 1983;5:215–221
  32. Meltzer HY, Lowy M, Robertson A, Goodnick P, Perline R. Effect of 5-hydroxytryptophan on serum cortisol levels in major disorders. III. Effect of antidepressants and lithium carbonate. Archives of Genetic Psychiatry. 1984;41:391–397
  33. Modai I, Zemishlany Z, Jerushalmy Z. 5-Hydroxytryptamine uptake by blood platelets of unipolar and bipolar depressed patients. Neuropsychobiology. 1984;12:93–95
  34. Murphy DL, Colburn RW, Davis JM, Bunney WE. Stimulation by lithium on monoamine uptake in human platelets. Life Sciences. 1969;8:1187–1194
  35. Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. American Journal of Psychiatry. 1995;152:850–855
  36. Peters JR, Geaney DP, Grahame-Smith DG. 5-[3H]Hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets. Methods in Enzymology. 1992;215:201–213
  37. Plenge P, Mellerup ET. 3H-Imipramine high-affinity binding sites in rat brain. Effects of imipramine and lithium. Psychopharmacology. 1982;77:94–97
  38. Plenge P, Mellerup ET, Jorgensen OS. Lithium treatment regimens induce different changes in [3H]paroxetine binding protein and other rat brain proteins. Psychopharmacology. 1992;106:131–135
  39. Poirier MF, Galzin AM, Pimoule C, Schoemaker H, Le Quan Bui KH, Meyer P, et al. Short-term lithium administration to healthy volunteers produces lasting pronounced changes in platelet serotonin uptake but not imipramine binding. Psychopharmacology. 1988;94:521–526
  40. Power AC, Dorkins CE, Cowen PJ. Effect of lithium on the prolactin response to d-fenfluramine in healthy subjects. Biological Psychiatry. 1993;33:801–805
  41. Price LH, Charney DS, Delgado PL, Heninger GR. Lithium treatment and serotonergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Archives of General Psychiatry. 1989;46:13–19
  42. Rausch JL, Janowsky DS, Risch SC, Huey LY. A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients. Psychiatry Research. 1986;19:105–112
  43. Scott M, Reading HW, Loudon JB. Studies on human blood platelets in affective disorders. Psychopharmacology. 1979;60:131–135
  44. Smith PK, Krohn RI, Hermansson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Analytical Biochemistry. 1985;150:76–85
  45. Stain-Malmgren R, Tham A, Åberg-Wistedt A. Increased platelet 5-HT2 receptor binding after electroconvulsive therapy in depression. Journal of ECT. 1998;14:15–24
  46. Swann AC, Heninger GR, Roth RH, Maas JW. Differential effects of short- and long-term lithium on uptake and serotonergic function in cat brain. Life Sciences. 1981;28:347–354
  47. Tomasiak M. The effect of quercetin and lithium ions on platelet aggregation. Roczniki Akademii Medycznej w Bialymstoku. 1992;37:38–45
  48. Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar K. Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science. 1981;213:1529–1531
  49. Tuomisto J, Tukiainen E. Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature. 1976;262:596–598
  50. Vetulani J, Lebrecht U, Pilc A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. European Journal of Pharmacology. 1981;76:81–85
  51. Wood K, Swade C, Abou-Saleh MT, Coppen A. Peripheral serotonergic receptor sensitivity in depressive illness. Journal of Affective Disorders. 1984;7:59–65
  52. Wood K, Swade C, Abou-Saleh MT, Coppen A. Apparent supersensitivity of platelet receptors in lithium-treated patients. Journal of Affective Disorders. 1985;8:69–72
  53. Zivin JA, Waud DR. How to analyze binding, enzyme and uptake data: the simplest case, a single phase. Life Sciences. 1982;30:1407–1422

PII: S0165-1781(01)00314-6

Psychiatry Research
Volume 105, Issue 1 , Pages 33-44 , 15 December 2001

Article Tools

* Image Usage & Resolution